IVVD
Invivyd, Inc.
Biopharmaceutical company developing antibody-based therapies for serious viral infectious diseases via its proprietary INVYMAB platform
CUSIP: 00534A102HealthcareUS1 holder
Recent Activity
2025Q3
1 buy
+8.74M shares(+85.5%)
+8.74M shares(+85.5%)
Loading more activity...